A novel BRCA1 splicing variant detected in an early onset triple-negative breast cancer patient additionally carrying a pathogenic variant in ATM: A case report
Article in Frontiers in Oncology (March 2023)
The most recent citing publications are shown below. View all 10 publications that cite this research output on Dimensions.
NRF2 Mediates Cellular Resistance to Transformation, Radiation, and Inflammation in Mice
Article in Antioxidants (August 2022)
Double heterozygous pathogenic variants prevalence in a cohort of patients with hereditary breast cancer
Article in Frontiers in Oncology (August 2022)